Multimodal Analgesia (MMA) Versus Patient-Controlled Analgesia (PCA) for One or Two-Level Posterior Lumbar Fusion Surgery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Sung-Woo | - |
dc.contributor.author | Cho, Hyeung-Kyu | - |
dc.contributor.author | Park, Suyeon | - |
dc.contributor.author | Yoo, Jae Hwa | - |
dc.contributor.author | Lee, Jae Chul | - |
dc.contributor.author | Baek, Min Jung | - |
dc.contributor.author | Jang, Hae-Dong | - |
dc.contributor.author | Cha, Joong Suk | - |
dc.contributor.author | Shin, Byung-Joon | - |
dc.date.accessioned | 2021-08-11T08:36:34Z | - |
dc.date.available | 2021-08-11T08:36:34Z | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2957 | - |
dc.description.abstract | A multimodal analgesic method was known to avoid the high-dose requirements and dose-dependent adverse events of opioids, and to achieve synergistic effects. The purpose of this study was to compare the efficacy of our multimodal analgesia (MMA) regimen with that of the patient-controlled analgesia (PCA) method for acute postoperative pain management. Patients who underwent one or two-level posterior lumbar fusion (PLF) followed by either MMA or PCA administration at our hospital were compared for pain score, additional opioid and non-opioid consumption, side effects, length of hospital stay, cost of pain control, and patient satisfaction. From 2016 through 2017, a total 146 of patients were screened. After propensity score matching, 66 remained in the PCA and 34 in the MMA group. Compared with the PCA group, the MMA group had a shorter length of hospital stay (median (interquartile range): 7 days (5-8) vs. 8 (7-11); P = 0.001) and lower cost of pain control (70.6 +/- 0.9 USD vs. 173.4 +/- 3.3, P < 0.001). Baseline data, clinical characteristics, pain score, additional non-opioid consumption, side effects, and patient subjective satisfaction score were similar between the two groups. The MMA seems to be a good alternative to the PCA after one or two-level PLF. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | Multimodal Analgesia (MMA) Versus Patient-Controlled Analgesia (PCA) for One or Two-Level Posterior Lumbar Fusion Surgery | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/jcm9041087 | - |
dc.identifier.scopusid | 2-s2.0-85091317003 | - |
dc.identifier.wosid | 000531821000194 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, v.9, no.4 | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.volume | 9 | - |
dc.citation.number | 4 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | POSTOPERATIVE PAIN MANAGEMENT | - |
dc.subject.keywordPlus | PROPENSITY | - |
dc.subject.keywordPlus | DECOMPRESSION | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | MORPHINE | - |
dc.subject.keywordAuthor | multimodal treatment | - |
dc.subject.keywordAuthor | analgesia | - |
dc.subject.keywordAuthor | patient-controlled | - |
dc.subject.keywordAuthor | lumbar vertebra | - |
dc.subject.keywordAuthor | arthrodesis | - |
dc.subject.keywordAuthor | pain | - |
dc.subject.keywordAuthor | postoperative | - |
dc.subject.keywordAuthor | length of stay | - |
dc.subject.keywordAuthor | cost | - |
dc.subject.keywordAuthor | preemptive | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.